Subjects -> PATENTS, TRADEMARKS AND COPYRIGHTS (Total: 28 journals)
|
|
|
- P2X receptor antagonists and their potential as therapeutics: a patent
review (2010–2021)-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Chianna Dane, Leanne Stokes, William T Jorgensen Pages: 1 - 22 Abstract: .
Citation: Expert Opinion on Therapeutic Patents PubDate: 2022-05-11T01:09:40Z DOI: 10.1080/13543776.2022.2069010
- Carbon-11 patents (2012–2022): synthetic methodologies and novel
radiotracers for PET imaging-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Sridhar Goud Nerella, Priti Singh, Sanam Tulja Pages: 1 - 15 Abstract: .
Citation: Expert Opinion on Therapeutic Patents PubDate: 2022-04-28T07:49:34Z DOI: 10.1080/13543776.2022.2070003
- Anti-viral activity of thiazole derivatives: an updated patent review
-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Thoraya A. Farghaly, Amani M. R. Alsaedi, Noof A. Alenazi, Marwa F. Harras Pages: 1 - 25 Abstract: .
Citation: Expert Opinion on Therapeutic Patents PubDate: 2022-04-27T07:00:49Z DOI: 10.1080/13543776.2022.2067477
- ATP-citrate lyase (ACLY) inhibitors as therapeutic agents: a patenting
perspective-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Carlotta Granchi Pages: 1 - 12 Abstract: .
Citation: Expert Opinion on Therapeutic Patents PubDate: 2022-04-25T06:20:59Z DOI: 10.1080/13543776.2022.2067478
- Soluble epoxide hydrolase inhibitors: an overview and patent review from
the last decade-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Malliga R. Iyer, Biswajit Kundu, Casey M. Wood Pages: 1 - 19 Abstract: .
Citation: Expert Opinion on Therapeutic Patents PubDate: 2022-04-12T07:47:43Z DOI: 10.1080/13543776.2022.2054329
- Nucleotide pyrophosphatase/phosphodiesterases (NPPs) including NPP1 and
NPP2/ ATX as important drug targets: A patent review (2015-2020)-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Sehrish Bano, Mariya Al-Rashida, Rima D Alharthy, Imtiaz Ali Khan, Jamshed Iqbal Pages: 1 - 9 Abstract: .
Citation: Expert Opinion on Therapeutic Patents PubDate: 2022-04-12T07:01:29Z DOI: 10.1080/13543776.2022.2058874
- A patent review of adenosine A2B receptor antagonists (2016-present)
-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Beatrice Francucci, Diego Dal Ben, Catia Lambertucci, Andrea Spinaci, Rosaria Volpini, Gabriella Marucci, Michela Buccioni Pages: 1 - 24 Abstract: .
Citation: Expert Opinion on Therapeutic Patents PubDate: 2022-04-07T07:40:57Z DOI: 10.1080/13543776.2022.2057222
- The intriguing role of USP30 inhibitors as deubiquitinating enzymes from
the patent literature since 2013-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Sofia Ferrer, Michael E. Muratore, Peter Buijnsters Pages: 1 - 37 Abstract: .
Citation: Expert Opinion on Therapeutic Patents PubDate: 2022-04-04T08:19:16Z DOI: 10.1080/13543776.2022.2003780
- An updated patent review of small-molecule ROS1 kinase inhibitors
(2015–2021)-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Meng Liu, Jintian Dai, Mudan Wei, Qingshan Pan, Wufu Zhu Pages: 1 - 17 Abstract: .
Citation: Expert Opinion on Therapeutic Patents PubDate: 2022-04-01T07:48:43Z DOI: 10.1080/13543776.2022.2058872
- Novel inhibitors of the STAT3 signaling pathway: an updated patent review
(2014-present)-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Feng Wang, Xin-Yu Cao, Guo-Qiang Lin, Ping Tian, Dingding Gao Pages: 1 - 22 Abstract: .
Citation: Expert Opinion on Therapeutic Patents PubDate: 2022-04-01T07:44:36Z DOI: 10.1080/13543776.2022.2056013
- A patent review of ubiquitin-specific protease 7 (USP7) inhibitors
(2014-present)-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Peng Li, Ying Liu, Hong-Min Liu Pages: 1 - 15 Abstract: .
Citation: Expert Opinion on Therapeutic Patents PubDate: 2022-03-31T12:21:15Z DOI: 10.1080/13543776.2022.2058873
- Dopamine D3 receptor ligands: a patent review (2014–2020)
-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Rita Maria Concetta Di Martino, Andrea Cavalli, Giovanni Bottegoni Pages: 1 - 23 Abstract: .
Citation: Expert Opinion on Therapeutic Patents PubDate: 2022-03-24T07:06:51Z DOI: 10.1080/13543776.2022.2049240
- Malaria transmission blocking compounds: a patent review
-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Sara Consalvi, Chiara Tammaro, Federico Appetecchia, Mariangela Biava, Giovanna Poce Pages: 1 - 18 Abstract: .
Citation: Expert Opinion on Therapeutic Patents PubDate: 2022-03-11T12:48:44Z DOI: 10.1080/13543776.2022.2049239
- Small molecules as kinetoplastid specific proteasome inhibitors for
leishmaniasis: a patent review from 1998 to 2021-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Mohd Imran, Shah Alam Khan, Abida, Ahmed Subeh Alshrari, Mahmoud Mudawi Eltahir Mudawi, Mohammed Kanan Alshammari, Aishah Ali Harshan, Noufah Aqeel Alshammari Pages: 1 - 14 Abstract: .
Citation: Expert Opinion on Therapeutic Patents PubDate: 2022-03-11T08:04:45Z DOI: 10.1080/13543776.2022.2045948
- Menin-MLL protein-protein interaction inhibitors: a patent review
(2014–2021)-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Huanrong Bai, San-Qi Zhang, Hao Lei, Fang Wang, Mengyan Ma, Minhang Xin Pages: 1 - 16 Abstract: .
Citation: Expert Opinion on Therapeutic Patents PubDate: 2022-03-11T08:02:41Z DOI: 10.1080/13543776.2022.2045947
- Small Molecule Inhibitors of Programmed Cell Death Ligand 1 (PD-L1): A
Patent Review (2019–2021)-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Jingjing Deng, Zhengqi Cheng, Juyang Long, Alexander Dömling, Micky Tortorella, Yuanze Wang Pages: 1 - 15 Abstract: .
Citation: Expert Opinion on Therapeutic Patents PubDate: 2022-03-11T07:58:50Z DOI: 10.1080/13543776.2022.2045276
- A patent review on cathepsin K inhibitors to treat osteoporosis (2011
– 2021)-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Fernanda R. Rocho, Vinícius Bonatto, Rafael F. Lameiro, Jerônimo Lameira, Andrei Leitão, Carlos A. Montanari Pages: 1 - 13 Abstract: .
Citation: Expert Opinion on Therapeutic Patents PubDate: 2022-03-10T04:15:45Z DOI: 10.1080/13543776.2022.2040480
- Inhibitors of the GTPase KRASG12C in cancer: a patent review (2019-2021)
-
Free pre-print version: Loading...
Rate this result:
What is this?
Please help us test our new pre-print finding feature by giving the pre-print link a rating. A 5 star rating indicates the linked pre-print has the exact same content as the published article.
Authors: Qifu Xu, Guozhen Zhang, Qian Liu, Shunda Li, Yingjie Zhang Pages: 1 - 31 Abstract: .
Citation: Expert Opinion on Therapeutic Patents PubDate: 2022-02-22T05:17:53Z DOI: 10.1080/13543776.2022.2032648
|